Amneal Pharmaceuticals Inc. Earnings

Amneal Pharmaceuticals Inc.’s revenue jumped 11.68% since last year same period to $784.51Mn in the Q3 2025. On a quarterly growth basis, Amneal Pharmaceuticals Inc. has generated 8.28% jump in its revenue since last 3-months.

Amneal Pharmaceuticals Inc.’s net profit jumped 1618.59% since last year same period to $2.37Mn in the Q3 2025. On a quarterly growth basis, Amneal Pharmaceuticals Inc. has generated -89.43% fall in its net profits since last 3-months.

Amneal Pharmaceuticals Inc.’s net profit margin jumped 1459.77% since last year same period to 0.3% in the Q3 2025. On a quarterly growth basis, Amneal Pharmaceuticals Inc. has generated -90.24% fall in its net profit margins since last 3-months.

Amneal Pharmaceuticals Inc.’s earning per share (EPS) estimates for the current quarter stand at 0.16 - a -7.35% fall from last quarter’s estimates.

Amneal Pharmaceuticals Inc.’s earning per share (EPS) estimates for the current year stand at 0.16.

Amneal Pharmaceuticals Inc.’s earning per share (EPS) fell -100% since last year same period to 0 in the Q3 2025. This indicates that the Amneal Pharmaceuticals Inc. has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.